These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15999465)

  • 1. The effect of orlistat-induced weight loss on interleukin-6 and C-reactive protein levels in obese subjects.
    Yesilbursa D; Serdar A; Heper Y; Sarac M; Coskun S; Kazazoglu AR; Cordan J
    Acta Cardiol; 2005 Jun; 60(3):265-9. PubMed ID: 15999465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study.
    Madsen EL; Rissanen A; Bruun JM; Skogstrand K; Tonstad S; Hougaard DM; Richelsen B
    Eur J Endocrinol; 2008 Feb; 158(2):179-87. PubMed ID: 18230824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects.
    Belza A; Toubro S; Stender S; Astrup A
    Int J Obes (Lond); 2009 Apr; 33(4):456-64. PubMed ID: 19238154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women.
    Bougoulia M; Triantos A; Koliakos G
    Hormones (Athens); 2006; 5(4):259-69. PubMed ID: 17178701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors.
    Samuelsson L; Gottsäter A; Lindgärde F
    Diabetes Obes Metab; 2003 May; 5(3):195-201. PubMed ID: 12681027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].
    Drummond M; Winck J; Guimarães J; Santos AC; Almeida J; Marques J
    Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity.
    Khaodhiar L; Ling PR; Blackburn GL; Bistrian BR
    JPEN J Parenter Enteral Nutr; 2004; 28(6):410-5. PubMed ID: 15568287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of weight loss on proinflammatory state of mononuclear cells in obese women.
    Sheu WH; Chang TM; Lee WJ; Ou HC; Wu CM; Tseng LN; Lang HF; Wu CS; Wan CJ; Lee IT
    Obesity (Silver Spring); 2008 May; 16(5):1033-8. PubMed ID: 18356846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?
    Bahceci M; Gokalp D; Bahceci S; Tuzcu A; Atmaca S; Arikan S
    J Endocrinol Invest; 2007 Mar; 30(3):210-4. PubMed ID: 17505154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects.
    Holdstock C; Lind L; Engstrom BE; Ohrvall M; Sundbom M; Larsson A; Karlsson FA
    Int J Obes (Lond); 2005 Oct; 29(10):1275-80. PubMed ID: 16010285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.
    Esposito K; Pontillo A; Di Palo C; Giugliano G; Masella M; Marfella R; Giugliano D
    JAMA; 2003 Apr; 289(14):1799-804. PubMed ID: 12684358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
    Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
    Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women.
    Laimer M; Kaser S; Kranebitter M; Sandhofer A; Mühlmann G; Schwelberger H; Weiss H; Patsch JR; Ebenbichler CF
    Int J Obes (Lond); 2005 May; 29(5):498-501. PubMed ID: 15685246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma interleukin-6 levels, glutathione peroxidase and isoprostane in obese women before and after weight loss. Association with cardiovascular risk factors.
    Bougoulia M; Triantos A; Koliakos G
    Hormones (Athens); 2006; 5(3):192-9. PubMed ID: 16950753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects.
    Möller K; Ostermann AI; Rund K; Thoms S; Blume C; Stahl F; Hahn A; Schebb NH; Schuchardt JP
    Prostaglandins Leukot Essent Fatty Acids; 2016 Mar; 106():39-49. PubMed ID: 26751601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial.
    Ellulu MS; Rahmat A; Patimah I; Khaza'ai H; Abed Y
    Drug Des Devel Ther; 2015; 9():3405-12. PubMed ID: 26170625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome.
    Heinonen MV; Laaksonen DE; Karhu T; Karhunen L; Laitinen T; Kainulainen S; Rissanen A; Niskanen L; Herzig KH
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):626-33. PubMed ID: 19278844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and Inflammatory Changes with Orlistat and Sibutramine Treatment in Obese Malaysian Subjects.
    Al-Tahami BAM; Al-Safi Ismail AA; Sanip Z; Yusoff Z; Shihabudin TMT; Singh TSP; Rasool AHG
    J Nippon Med Sch; 2017; 84(3):125-132. PubMed ID: 28724846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Maffioli P
    J Clin Pharm Ther; 2012 Apr; 37(2):187-95. PubMed ID: 21812797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.